Zobrazeno 1 - 5
of 5
pro vyhledávání: '"James, Orsini"'
Autor:
Benjamin L, Musher, Joshua E, Melson, Gianni, Amato, David, Chan, Marisa, Hill, Iftekhar, Khan, Samith T, Kochuparambil, Susan E, Lyons, James, Orsini, Susanne K, Pedersen, Bruce, Robb, Joel, Saltzman, Jennifer, Silinsky, Snigdha, Gaur, Melissa K, Tuck, Lawrence C, LaPointe, Graeme P, Young
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 29(12)
Most recurrences of early-stage colorectal cancer detected with current surveillance measures are widespread and incurable. Circulating tumor DNA (ctDNA) may facilitate earlier diagnosis of recurrent colorectal cancer and improve cancer-related outco
Publikováno v:
Journal of Endocrinology and Metabolism. 5:256-260
Autor:
Musher, Benjamin L., Melson, Joshua E., Amato, Gianni, Chan, David, Hill, Marisa, Khan, Iftekhar, Kochuparambil, Samith T., Lyons, Susan E., Jr, James Orsini, Pedersen, Susanne K., Robb, Bruce, Saltzman, Joel, Silinsky, Jennifer, Gaur, Snigdha, Tuck, Melissa K., LaPointe, Lawrence C., Young, Graeme P.
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention; Dec2020, Vol. 29 Issue 12, p2702-2709, 8p
Autor:
James Orsini, Priya Mehta, Zaza Cohen, Prashant Parashurama, Fiore Devito, Lan Wang, Rini Abraham, Bijal Mehta, Wesley Ablemona, Pratima Dibba
Publikováno v:
American Journal of Gastroenterology. 111:S1029-S1030
Autor:
Alfred Rademaker, Yishai Ofran, Elizabeth H. Cull, Sharona Lee Ram, George Mallios, Stephen D. Nimer, Joseph G. Jurcic, Todd L. Rosenblat, Sonia Sandhu, Jacob M. Rowe, Steven Trifilio, Martin S. Tallman, Jae H. Park, Jessica K. Altman, Tony DeBlasio, Olga Frankfurt, Dan Douer, Augustin Haidau, Rose Catchatourian, Nelly G. Adel, James Orsini, Bing Bing Weitner
Publikováno v:
Blood. 118:942-942
Abstract 942 Background: Early death in APL, most often due to bleeding, has emerged as the major cause of treatment failure now that curative strategies exist. Despite the routine use of ATRA, EDR remains high (Lehmann et al Leukemia 2011, Park et a